Painkiller Aspirin will be part of a trial to determine whether the painkiller can reduce the risk of dangerous blood clots caused by the coronavirus.
Aspirin is an antiplatelet agent and can reduce the risk of clots. Patients infected with the coronavirus are at a higher risk of blood clots because of hyper-reactive platelets, the cell fragments that help stop bleeding.
The cheap and widely available drug has been added to a list of potential treatments to be tested as part of the Randomised Evaluation of Covid-19 therapy (Recovery) trial, one of the biggest in Britain.
The scientists behind the RECOVERY trial, which is looking into a range of potential treatments for COVID-19, said it would include the drug, which is commonly used as a blood thinner.
“There is a clear rationale for believing that it (aspirin) might be beneficial, and it is safe, inexpensive, and widely available,” said Peter Horby, Co-Chief Investigator of the trial.
Experts hope that aspirin, an antiplatelet agent that is commonly used as a blood thinner, can reduce the possibility of clotting complications.